[go: up one dir, main page]

WO2008018111A3 - Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections - Google Patents

Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections Download PDF

Info

Publication number
WO2008018111A3
WO2008018111A3 PCT/IT2007/000578 IT2007000578W WO2008018111A3 WO 2008018111 A3 WO2008018111 A3 WO 2008018111A3 IT 2007000578 W IT2007000578 W IT 2007000578W WO 2008018111 A3 WO2008018111 A3 WO 2008018111A3
Authority
WO
WIPO (PCT)
Prior art keywords
lactoferrin
prevention
treatment
urinary tract
tract infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IT2007/000578
Other languages
French (fr)
Other versions
WO2008018111A2 (en
Inventor
Giulia Falcone
Enrico Boldrini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opocrin SpA
Original Assignee
Opocrin SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opocrin SpA filed Critical Opocrin SpA
Publication of WO2008018111A2 publication Critical patent/WO2008018111A2/en
Publication of WO2008018111A3 publication Critical patent/WO2008018111A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composition for the prevention and treatment of urinary tract infections containing, in combination, therapeutically effective quantities of cranberry (Vacciniυm macrocarpon) and lactoferrin, for oral administration, in which the known antimicrobial action of cranberry is enhanced by a synergistic interaction with lactoferrin. The invention also concerns the use of cranberry and lactoferrin, in combination, for the production of a composition for the prevention and treatment of urinary tract infections, particularly indicated as a natural alternative to antibiotic therapy, or as a co-adjuvant in the said therapy, particularly in the prevention of recurrent urinary infections.
PCT/IT2007/000578 2006-08-09 2007-08-08 Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections Ceased WO2008018111A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000435A ITRM20060435A1 (en) 2006-08-09 2006-08-09 COMPOSITION BASED ON RED CRANBERRY VACCINIUM MCROCARPON AND LATTOFERRINA FOR THE PREVENTION AND TREATMENT OF URINARY TRACT INFECTIONS
ITRM2006A000435 2006-08-09

Publications (2)

Publication Number Publication Date
WO2008018111A2 WO2008018111A2 (en) 2008-02-14
WO2008018111A3 true WO2008018111A3 (en) 2008-03-20

Family

ID=38616276

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2007/000578 Ceased WO2008018111A2 (en) 2006-08-09 2007-08-08 Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections

Country Status (2)

Country Link
IT (1) ITRM20060435A1 (en)
WO (1) WO2008018111A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010078660A1 (en) * 2009-01-12 2010-07-15 The Royal Institution For The Advancement Of Learning/Mcgill University Use of proanthocyanidins as an anti-apoptotic agent and anti-adhesive bacterial agent
FR2959938B1 (en) * 2010-05-12 2012-09-07 Gunter Haesaerts URINARY PROBE COMPRISING PROANTHOCYANIDINES AND USE THEREOF
WO2017112783A1 (en) * 2015-12-23 2017-06-29 Ocean Spray Cranberries, Inc. Fruit chew supplements
MX2017016991A (en) * 2017-12-20 2019-06-21 Centro De Retina Medica Y Quirurgica S C Oral administration formulation of blueberry extract as a coadjuvant for preserving the health of human precorneal film.
GR1009632B (en) * 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Nutritional supplement for the oral administration of a combination of lactoferrin, xyloglucan, proanthocyanidin and simethicone against the infections of the gastrointestinal and urinary tract

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753308A2 (en) * 1995-07-12 1997-01-15 Gambit International Limited Use of lactoferrin for therapy of acute or recurrent infectious diseases by streptococcus pyogenes or other intracellular gram positive pathogen bacteria
WO2000047174A1 (en) * 1999-02-12 2000-08-17 Pharmacal Biotechnologies, Llc Compositions for controlling bacterial colonization
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
US20010012525A1 (en) * 1998-04-30 2001-08-09 Mann Douglas L. Infused vegetable, herb, and/or seed fiber product and dietary supplements containing same
US20050158381A1 (en) * 2004-01-16 2005-07-21 Mary Aldritt Effervescent composition including cranberry extract
US20060269535A1 (en) * 2005-05-31 2006-11-30 Naidu A S Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753308A2 (en) * 1995-07-12 1997-01-15 Gambit International Limited Use of lactoferrin for therapy of acute or recurrent infectious diseases by streptococcus pyogenes or other intracellular gram positive pathogen bacteria
US20010012525A1 (en) * 1998-04-30 2001-08-09 Mann Douglas L. Infused vegetable, herb, and/or seed fiber product and dietary supplements containing same
WO2000047174A1 (en) * 1999-02-12 2000-08-17 Pharmacal Biotechnologies, Llc Compositions for controlling bacterial colonization
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
US20050158381A1 (en) * 2004-01-16 2005-07-21 Mary Aldritt Effervescent composition including cranberry extract
US20060269535A1 (en) * 2005-05-31 2006-11-30 Naidu A S Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy

Also Published As

Publication number Publication date
WO2008018111A2 (en) 2008-02-14
ITRM20060435A1 (en) 2008-02-10

Similar Documents

Publication Publication Date Title
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
WO2007121188A3 (en) Compositions and methods of using r(+) pramipexole
WO2007143607A3 (en) Method of treating atrophic vaginitis
WO2004041269A3 (en) New use for pharmaceutical composition
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
NZ593823A (en) Compositions and methods for the treatment or the prevention of infections by e. coli
MY169564A (en) Substituted dihydropyrazolones and their use
EP4327867A3 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2007109192A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109172A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109154A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2009040445A3 (en) Arabinoxylo-oligosaccharides useful against gastrointestinal infections
ZA200709520B (en) Use of TFPI to treat severe bacterial infections
PL2083809T3 (en) Dietary or pharmaceutical compositions containing tricyclic diterpenes for the treatment of depression.
WO2007109182A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2009037583A3 (en) Compositions and methods for treatment and prevention of osteoarthritis
WO2007109201A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
JO2721B1 (en) Artemisinin Derivative Dimers, Their preparation and their therapeutic application
WO2007100561A3 (en) Use of dha and ara in the preparation of a composition for preventing or treating obesity
WO2007100435A3 (en) Use of dha and ara in the preparation of a composition for the prevention or treatment of anemia
WO2008018111A3 (en) Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections
WO2008036761A8 (en) Anti-microbial defensin-related peptides and methods of use
WO2008004224A3 (en) Synergistic compositions for crohn's disease and inflammatory gastrointestinal disorders
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07805769

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07805769

Country of ref document: EP

Kind code of ref document: A2